A Neurobiological Hypothesis of Treatment-Resistant Depression – Mechanisms for Selective Serotonin Reuptake Inhibitor Non-Efficacy

First-line treatment of major depression includes administration of a selective serotonin reuptake inhibitor (SSRI), yet studies suggest that remission rates following two trials of an SSRI are <50%. The authors examine the putative biological substrates underlying “treatment resistant depression...

Descripción completa

Detalles Bibliográficos
Autores principales: Coplan, Jeremy D., Gopinath, Srinath, Abdallah, Chadi G., Berry, Benjamin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033019/
https://www.ncbi.nlm.nih.gov/pubmed/24904340
http://dx.doi.org/10.3389/fnbeh.2014.00189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033019/
https://www.ncbi.nlm.nih.gov/pubmed/24904340
http://dx.doi.org/10.3389/fnbeh.2014.00189

Ejemplares similares